PBI3 Comparative Efficacy of Guselkumab and Tildrakizumab in Moderate-to-Severe Plaque Psoriasis: A Matching-Adjusted Indirect Comparison
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.081
https://www.valueinhealthjournal.com/article/S1098-3015(20)32337-8/fulltext
Title :
PBI3 Comparative Efficacy of Guselkumab and Tildrakizumab in Moderate-to-Severe Plaque Psoriasis: A Matching-Adjusted Indirect Comparison
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32337-8&doi=10.1016/j.jval.2020.08.081
First page :
Section Title :
Open access? :
No
Section Order :
10053